1 option
Emerging strategies in antibacterial drug resistance management : mechanisms, challenges, and novel interventions / Ajmer Singh Grewal, [and four others] editors.
- Format:
- Book
- Series:
- Microbiology research advances series.
- Microbiology Research Advances Series
- Language:
- English
- Subjects (All):
- Drug resistance in microorganisms.
- Anti-infective agents.
- Bacterial diseases--Complications.
- Bacterial diseases.
- Physical Description:
- 1 online resource (308 pages)
- Edition:
- First edition.
- Place of Publication:
- New York : Nova Science Publishers, Inc., [2024]
- Summary:
- "This book is an in-depth and comprehensive resource that addresses the growing crisis of antimicrobial drug resistance (AMR). This book delves into the complexities of AMR, offering a detailed exploration of the mechanisms behind resistance, the environmental and genetic factors that facilitate it, and the broad ecological impacts it has. This book begins with an introduction to antimicrobial drug resistance, setting a foundational understanding of the scope and scale of the problem. It then progresses into a thorough analysis of the mechanisms by which microbes develop resistance, such as genetic mutations and the acquisition of resistance genes through horizontal gene transfer. A significant portion of the book is dedicated to examining the environmental and genetic factors associated with antimicrobial drug resistance. Additionally, the text explores the impact of antimicrobial drugs on micro-biodiversity, shedding light on how these drugs disrupt microbial communities and the balance of ecosystems. This book also considers the indirect effects of antimicrobial drugs on flora and fauna, emphasizing the far-reaching ecological consequences of widespread antimicrobial use. A central theme of the book is the exploration of emerging strategies in antibacterial drug resistance management. It discusses novel mechanisms and interventions that are being developed to combat resistance, highlighting the innovative approaches and the challenges they face. This book also explores anti-virulence therapeutic approaches that target the virulence factors of bacteria rather than their viability, thus reducing the selective pressure for resistance. Other cutting-edge strategies include targeting microbial biofilms, which are structured communities of bacteria that are particularly resistant to antibiotics and developing targeted drug delivery systems to enhance the efficacy of antimicrobial treatments. Natural products are another area of focus, with chapters dedicated to the potential of algal products and lantibiotics as alternatives to traditional antibiotics. Further, the book addresses the challenges of water and sanitation in relation to AMR, emphasizing the role of inadequate infrastructure and poor practices in the spread of resistant microbes. The influence of poultry farming on AMR is examined, highlighting the extensive use of antibiotics in agriculture and its impact on resistance patterns. Advanced topics include the application of computational biology and nanotechnology in the fight against AMR. Computational biology aids in the prediction and design of new antimicrobial agents, while nanotechnology-based approaches offer innovative solutions for overcoming bacterial defences. This book also touches on the implications of the COVID-19 pandemic on antimicrobial drug resistance, discussing how the pandemic has influenced resistance patterns and healthcare practices. It concludes by framing AMR as a global menace with significant social health and environmental implications, stressing the urgent need for coordinated global action. This book is an essential reference for researchers, healthcare professionals, and policymakers. It provides a holistic view of the AMR crisis and offers a diverse array of strategies to mitigate this critical global health threat"-- Provided by publisher.
- Contents:
- Intro
- Contents
- Preface
- Chapter 1
- Introduction to Antimicrobial Drug Resistance
- Abstract
- Abbreviations
- Introduction
- Antibiotic Resistance
- Pathogenic Microorganisms and Hyper Drug-Resistant Means
- Mechanisms of Drug Resistance and M. tuberculosis
- Pharmaceutical Resistance Mechanisms and V. cholerae
- Candida Species and Mechanisms of Drug Resistance
- Whether to Be Resistant or Not: The Reasons Behind and Mechanisms of Antibiotic Resistance Development and Transmission among Bacteria
- Resistance Gene Transmission: Horizontal and Vertical
- Issues Affecting the Development of Novel Antibiotics
- Traditional Antibacterial Resistance's Difficulties
- Novel Antimicrobials
- Inhibitors of β-Lactamase
- Combination Antibiotic Treatment
- Vaccines
- New Approaches to Address Antibacterial Resistance
- Combinatorial Therapy Approach
- Bacteriophage Therapy Approach
- Immuno-Therapeutic Approaches
- CRISPR/Cas Based Approaches
- Conclusion
- References
- Chapter 2
- Mechanisms of Antimicrobial Drug Resistance
- Antibacterial Medication Action Mechanisms
- Interference with the Creation of the Cell Wall
- Protein Synthesis Inhibition
- Disruption of the Production of Nucleic Acids
- Inhibiting DNA Dynthesis
- Suppress RNA Synthesis
- Mechanisms of Developing Antibacterial Resistance
- Antibiotic Molecule Modification
- Antibiotic Molecule Destruction
- Reduced Antibiotic Entry and Increased Efflux
- Reduced Permeability
- Efflux Pumps
- Changes in Target Sites
- Target Protection
- Modification of the Target Site
- Mutations Result in Changes to the Target Site
- Chapter 3
- Environmental and Genetic Factors Associated with Antimicrobial Drug Resistance
- Introduction.
- Selection of AMR due to Environmental Stress Factors
- Limitation of Nutrients
- Oxidative Stress
- Enveloping Stress
- Environment Development of Resistance
- Impact of Pollution and Evolution of AMR Genes
- Natural AMR
- Challenges Faced in AMR in India
- Genetic Factors Associated with AMR
- Horizontal Gene Transfer
- Mutation
- Mobile Genetic Element
- Chapter 4
- Effect of Antimicrobial Drugs on Micro-Diversity
- Abbreviation
- The Intricate Impact of Antimicrobial Drugs on Microbial Diversity
- Microbial Communities in the Human Gut: A Microcosm of Effects
- Soil Ecosystems: Beneath the Surface Effects
- Aquatic Ecosystems: From Rivers to Oceans
- Disruption of Ecosystem Dynamics
- Research and Strategizing for Balance
- Balancing Benefits and Preservation
- A Precise Approach to Treatment
- A Microbial Toolbox: Harnessing Microbes as Allies
- Holistic Approaches: Integrating Clinical and Environmental Considerations
- Collaboration for Comprehensive Understanding
- Ecological Insight Informing Clinical Practice
- Policymaking for Sustainable Solutions
- A Holistic Strategy for Mitigation
- Educating for Awareness and Action
- Chapter 5
- Indirect Effects of Antimicrobial Drugs on Flora and Fauna
- Some Direct Effects of Antimicrobials on Flora and Fauna
- Treatment of Disease
- Resisting the Outbreak
- Growing Biodiversity
- Indirect Effect of Antimicrobials
- Antibiotic Residues in the Environment
- Effect on Marine Fauna and Flora
- Antibiotic Residues in Water Systems
- Impact on Soil Microbial Communities
- Antibiotic-Induced Changes in Plant Physiology
- Faunal Responses to Antibiotic Residues
- Impact on Microbial Communities.
- Alterations in Microbial Diversity and Abundance
- Development of Antibiotic Resistance
- Ecological Consequences in Soil and Water Environments
- Selective Pressures and Co-Selection of Resistance
- Resilience and Recovery of Microbial Communities
- Ecotoxicological Effects on Fauna
- Aquatic Fauna
- Impact on Fish
- Impact on Aquatic Invertebrates
- Terrestrial Fauna
- Impact on Soil Invertebrates
- Impact on Vertebrates
- Mechanisms of Toxicity
- Human Health Concerns
- Emergence and Spread
- Impact on Treatment Efficacy
- Disruption of the Human Microbiome
- Alteration of Gut Microbiota
- Long-Term Health Consequences
- Adverse Effects and Allergic Reactions
- Immediate Adverse Reactions
- Long-Term Safety Concerns
- Chapter 6
- Strategies for Prevention of Antimicrobial Drug Resistance
- International/National Measures/Strategies on AMR
- International Measures
- National Strategies
- Awareness at the Community Level on Rational Use of Antibiotics
- Rational Use of Antibiotics
- Over-the-Counter (OTC) Antibiotics
- Guidelines for the Use of Antibiotics at Local Levels
- Standards of Hygiene
- Other Approaches
- Strategies for Prevention to Reduce AMR
- Conventional Anti-Microbials and Combination Therapy-Based Approach
- Drug Delivery System-Based Approach
- Bacteria Resistant to Antibiotics: An Approach
- An Enzyme-Based Strategy Resistant to Microbes
- Enzymes That Degrade Polysaccharides
- Lysozyme
- Amylases
- Lyase Alginate
- The Enzymes That Digest Proteins
- Lipoprotein
- Supplementary Materials
- Lysins Of Bacteriophages
- Enzymes Oxidative
- Enzymes That Produce Hydrogen Peroxide
- Enzymes Sensitive to Hydrogen Peroxide
- Enzymes That Sense Anti-Quorum
- Physicochemical Methods.
- Atmospheric Pressure Non-Thermal Plasma (APNTP)
- Sonodynamic Antimicrobial Chemotherapy
- Photoinactivation
- Other Physicochemical Means
- Vaccines Potential Role in Combating AMR Pathogens
- Chapter 7
- Emerging Strategies in Antibacterial Drug Resistance Management: Mechanisms, Challenges, and Novel Interventions
- Combinational Drug Therapy
- Bacteriophage
- Antimicrobial Adjuvants
- Natural Product-Based Hybrid Molecule
- Nanotechnology for Targeted Drug Delivery
- Dendrimers
- Liposomes
- Metal Ions
- Chapter 8
- Outer Membrane Permeability Enhancer
- Structure of the Outer Membrane
- Lipopolysaccharides
- Porins
- Periplasmic Space
- Peptidoglycan
- Environmental Influences (Plasticity)
- Barrier Function Rather than Target Site
- Molecular Properties Necessary for Antibiotic Penetration
- Strategies to Overcome Penetration Constraints
- Permeabilizing Agents
- Effects on Outer Membrane Permeability
- Intracellular Delivery of Biocides
- Membrane Permeabilization
- Permeation Enhancers
- Lipid-Based Permeation Enhancers
- Phospholipids
- Essential Fatty Acids
- Compounds Derived from Plant
- Terpenes
- Flavonoids
- Protein-Based Permeation Enhancers
- Cell-Penetrating Peptides (CPPs)
- Enzymes
- Adsorbents
- Saponins
- Bile Salts
- Bioactive Compounds from Marine Sources
- Marine Peptides
- Marine Oils
- Chitosan
- Cyclodextrins
- Aloe Vera Gel
- Glycyrrhizin
- Menthol
- Polyphenols
- Acid Hyaluronic
- Silica Nanoparticles
- Quillaja Saponins
- Peppermint Oil
- Chapter 9
- Role of Efflux Pump Inhibitors in Antimicrobial Drug Resistance
- Types of Bacterial Efflux Systems
- ATP-Binding Cassette (ABC) Superfamily
- Resistance Nodulation Cell Division (RND) Superfamily
- Major Facilitator Superfamily (MFS)
- Multidrug and Toxic Compound Extrusion (MATE) Family
- Small Multidrug Resistance (SMR) Family
- Proteobacterial Antimicrobial Compound Efflux (PACE) Family
- Efflux Pump Inhibitors (EPIs)
- Synthetic EPIs
- Naturally Derived EPIs
- Current Challenges and Future Aspects for EPIs
- Chapter 10
- Anti-Virulence Therapeutic Approaches
- Virulence Factors and Mechanisms
- Mechanisms of Anti-Virulence Therapies
- Challenges and Limitations of Anti-Virulence Therapies
- Future Perspectives and Emerging Trends
- Advancements in Target Identification and Validation
- Personalized Anti-Virulence Therapies
- Combination Approaches
- Ethical and Social Considerations
- Balancing Anti-Virulence with Microbiome Preservation
- Equity and Access to Anti-Virulence Therapies
- Ethical Challenges in Phage Therapy and Genetic Manipulation
- Chapter 11
- Targeting Microbial Biofilms
- Current Approaches for Targeting Microbial Biofilms
- EPS-Targeting Strategies
- Targeting EPS Synthesis, Secretion and Binding of EPS Adhesions
- Targeting the EPS Chemical Composition, Structure and Inducing Biofilm Dispersal
- EPS-Targeted Epitopes within the Polysaccharide
- Enterococcus faecalis Vaccine for Urinary Tract Infections Associated with Catheter
- Multivalent Vaccine for Staphylococcus aureus Infections
- Targeting Integration Host Factor (IHF)
- Targeting Quorum Sensing
- Quorum Sensing Autoinducer 2 (AI-2)
- Autoinducing Peptide Type I (AIP-I)
- Metabolic Interference
- Targeting Dormant Cells in Biofilms.
- Acyldepsipeptide Antibiotic (ADEP4).
- Notes:
- Includes bibliographical references and index.
- Description based on publisher supplied metadata and other sources.
- Description based on print version record.
- ISBN:
- 9798895301401
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.